7th Annual Bio/Pharma Cold Chain China

2016-04-06

Balancing Compliance, Cost and Quality to Build Competitiveness – hear first hand updates on new regulation and successful stories from leading practitioners across the globe

China’s bio/pharmaceutical industry has shown the potential of continuous boom with the aging population, increasing disposable income and growing awareness of health needs.  However, the cold chain process remains complex and often endangers the quality and limits the growth of bio/pharma industry.

With accelerating changes and opportunities brought by newly released regulation such as revised GSP and soon-to-be released regulation such as ‘Internet food and drug Supervision and Management Measures’, companies are in danger of lagging behind in regulatory compliance, exploring new business model and enhancing quality with reduced cost. How to stand out from numerous competitors will heavily depend on business leaders, to effectively navigate the changes and develop sustainable strategies with innovative technology and collaborative partnerships.

The 7th Annual Bio/Pharma Cold Chain Summit 2016 brings to you distinguished leaders and their best practices, so that you can explore globally proven strategies and solutions for an optimized, efficient and secured cold chain for your company. Join us in Shanghai to elevate your cold chain process to a new level and network with the top industry leaders.

Please come and join us at Bio/Pharma 2016 in Shanghai!